Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/1999
03/25/1999CA2304312A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications
03/25/1999CA2304265A1 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol
03/25/1999CA2304119A1 Modulation of immune responses
03/25/1999CA2303227A1 Human prl-1 phosphatase
03/25/1999CA2303026A1 Method for the synthesis of quinoline derivatives
03/25/1999CA2302782A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999CA2244971A1 Mure
03/24/1999EP0903353A1 Imidazolidine derivates, their preparation and use, and pharmaceutical compositions containing them
03/24/1999EP0903349A2 CCR-3 receptor antagonists
03/24/1999EP0903345A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/24/1999EP0903339A2 Biphenylsulfonylcyanamides, process for their preparation and their use as medicaments
03/24/1999EP0903151A1 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
03/24/1999EP0902681A1 Inhibition of selectin binding
03/24/1999EP0745063B1 Substituted biphenyl derivatives as phosphodiesterase inhibitors
03/24/1999EP0673240B1 Stabilized medicinal aerosol solution formulations
03/24/1999EP0667855B1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
03/24/1999EP0563128B1 New 3,4-dihydroisoquinoline derivates and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines
03/24/1999CN1211572A Cyclic amine derivatives-CCR-3 receptor antagonists
03/23/1999US5886156 A complex of tri or teterapeptide covalently linked to the peptide either directly or through a linker and lipid or mixture of lipids; useful in treatment of respiratory distress syndrome
03/23/1999US5886009 Quinuclidine derivative as a substance P antagonist
03/23/1999US5885800 DNA encoding tumor necrosis related receptor, TR4
03/23/1999US5885572 Administering polypeptide or active fragment to treat bacterial infections
03/23/1999CA2247735A1 Novel 5-membered ring heterocycles, their preparation, their use and pharmaceutical preparations comprising them
03/23/1999CA2127462C Treatment for asthma
03/23/1999CA2022611C Optical resolution method for 3s-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4s-chromanol
03/23/1999CA1340463C Alkanophenones
03/23/1999CA1340461C Alveolar surfactant proteins
03/22/1999CA2247749A1 Biphenylsulfonylcyanamides, process for their preparation, and their use as medicament
03/22/1999CA2244239A1 Novel era
03/18/1999WO1999013064A2 Viral infection of cells using viral vectors
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999013054A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/18/1999WO1999012944A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
03/18/1999WO1999012936A1 Furopyrrolidine derivatives and their use as serine protease inhibitors
03/18/1999WO1999012935A1 Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors
03/18/1999WO1999012934A1 Pyrrolopyrrolone derivatives
03/18/1999WO1999012933A2 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999WO1999012932A1 Method of inhibiting serine protease enzymes
03/18/1999WO1999012931A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999WO1999012930A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999WO1999012921A1 Thromboxane ligands
03/18/1999WO1999012916A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/18/1999WO1999012915A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
03/18/1999WO1999012559A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999WO1999012542A1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
03/18/1999WO1999012523A1 Modulation of drug loading in multivesicular liposomes
03/18/1999WO1998058953A3 Surface exposed proteins from chlamydia pneumoniae
03/18/1999CA2304108A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303440A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999CA2303249A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999CA2303176A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999CA2303152A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
03/18/1999CA2302555A1 Thromboxane ligands
03/18/1999CA2302470A1 Synthetic divalent slex containing polylactosamines and methods for use
03/18/1999CA2300387A1 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/18/1999CA2296358A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/18/1999CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
03/17/1999EP0902018A2 2-(Arylphenyl)amino-imidazoline derivatives
03/17/1999EP0902013A1 Novel amidine derivatives, their preparation and their use as medicaments with LTB-4 antagonistic effect
03/17/1999EP0901482A1 Benzofuran carboxamides and their therapeutic use
03/17/1999EP0901470A1 Indole derivatives useful as endothelin receptor antagonists
03/17/1999EP0901463A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
03/17/1999EP0901379A2 Type-2 chemokine binding proteins and methods of use therefor
03/17/1999EP0789699B1 SPIRO[HETEROCYCLE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
03/17/1999EP0661975B1 Transdermal treatment of urticaria USING OPTICALLY PURE (+) CETIRIZINE
03/17/1999EP0626954B1 Benzocycloheptenes, benzoxepines and benzothiepines
03/17/1999EP0616536B1 Use of decorin or biglycan for the manufacture of a medicament in the treatment of diabetes-associated pathology
03/17/1999CN1211251A 1,4-dihydropyridine compounds as bradykinin antagonists
03/17/1999CN1211247A Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases
03/17/1999CN1211246A Novel substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases
03/17/1999CN1211242A Biologically active benzothiazolone ethananines
03/16/1999US5883239 aroA
03/16/1999US5883133 Cardiovascular disorders
03/16/1999US5883132 Multistage reaction of amidation, activation, coupling and hydrolysis
03/16/1999US5883114 Indolocarbazole imides and the use thereof
03/16/1999US5883090 Endothelin receptor antagonists
03/16/1999US5883075 Hypotensive agent cyclic peptides
03/16/1999US5882896 M protein
03/16/1999US5882885 Polypeptides and polynucleotides
03/16/1999US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae.
03/16/1999US5881720 Method of delivering halotherapy
03/16/1999CA2244232A1 Novel def
03/16/1999CA2186513C Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
03/16/1999CA2167198C Benzylaminoquinuclidines
03/16/1999CA2073226C Pyrazolopyrimidinone antianginal agents
03/11/1999WO1999011620A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
03/11/1999WO1999011275A2 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
03/11/1999WO1999011264A1 Il-8 receptor antagonists
03/11/1999WO1999011258A1 Lymphocyte function antigen-1 antagonists
03/11/1999WO1999011253A1 Il-8 receptor antagonists
03/11/1999WO1998052937A3 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
03/11/1999CA2302805A1 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
03/11/1999CA2302450A1 Il-8 receptor antagonists
03/11/1999CA2302364A1 Il-8 receptor antagonists
03/10/1999EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus
03/10/1999EP0900847A2 Phosphoribosyl transferase from Staphylococcus aureus
03/10/1999EP0900846A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
1 ... 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 ... 878